Table 3.
Model | HR (95% CI) | P |
---|---|---|
RFA versus PEI (n = 47 + 253) | ||
Adjustment by propensity score (n = 47 + 239) | ||
Linear | 1.11 (0.79–1.57) | 0.53 |
Cubic spline | 1.09 (0.77–1.54) | 0.63 |
Stratified (quintiles) | 1.11 (0.78–1.58) | 0.56 |
Inverse probability weighting | 1.13 (0.82–1.57) | 0.46 |
Adjustment by prognostic covariates (n = 47 + 253) | 1.21 (0.87–1.71) | 0.25 |
| ||
Surgery versus RFA/PEI (n = 34 + 303) | ||
Adjustment by propensity score (n = 34 + 255) | ||
Linear | 0.95 (0.64–1.41) | 0.79 |
Cubic spline | 0.95 (0.64–1.41) | 0.81 |
Stratified (quintiles) | 0.95 (0.61–1.48) | 0.82 |
Inverse probability weighting | 0.80 (0.52–1.24) | 0.32 |
Adjustment by prognostic covariates (n = 34 + 303) | 0.96 (0.64–1.42) | 0.82 |
| ||
TAE/TACE versus RFA/PEI (n = 80 + 303) | ||
Adjustment by propensity score (n = 80 + 287) | ||
Linear | 0.88 (0.66–1.17) | 0.38 |
Cubic spline | 0.89 (0.67–1.18) | 0.41 |
Stratified (quintiles) | 0.86 (0.65–1.15) | 0.32 |
Inverse probability weighting | 0.98 (0.73–1.32) | 0.90 |
Adjustment by prognostic covariates (n = 80 + 303) | 0.83 (0.63–1.10) | 0.20 |
PEI: percutaneous ethanol injection, RFA: radiofrequency ablation, TACE/TAE: transarterial embolization with (TACE) or without (TAE) chemotherapy.